It was shown that the improvement in hepatic steatosis among obese NAFLD patients who underwent bariatric surgery was accompanied with significant reduction in hepatic apoA-V mRNA levels[128]. Here, APOA5 is linked to metabolic dysfunction-associated steatotic liver disease.